JAMA Dermatology
2 stories
-
healthAI Boosts Skin Condition Recognition but Lacks Actionable Guidance
New study reveals AI tools enhance consumer ability to identify skin concerns, yet fall short in providing clear next steps for treatment.
-
healthLutikizumab Shows Promise for Hidradenitis Suppurativa After Anti-TNF Failure
Phase 2 trial reveals lutikizumab improves outcomes in moderate-to-severe hidradenitis suppurativa patients unresponsive to anti-TNF therapy.